Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | Substance-K receptor |
---|
Ligand | BDBM50081195 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Binding Competition Assay |
---|
Ki | 14000±n/a nM |
---|
Citation | Hoveyda, HR; Dutheuil, G; Fraser, GL; Roy, M; El Bousmaqui, M; Batt, F Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof US Patent US10941151 Publication Date 3/9/2021 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Substance-K receptor |
---|
Name: | Substance-K receptor |
Synonyms: | NK-2 receptor | NK-2R | NK2R | NK2R_HUMAN | NKNAR | Neurokinin 2 receptor | Neurokinin A receptor | Neurokinin NK2 | Neurokinin-2 (NK-2) | Neuromedin-2 receptor (NK-2R) | SKR | TAC2R | TACR2 | Tachykinin receptor 2 | Tachykinin receptor 2 (NK2) | hnk-3 |
Type: | Protein |
Mol. Mass.: | 44455.78 |
Organism: | Homo sapiens (Human) |
Description: | P21452 |
Residue: | 398 |
Sequence: | MGTCDIVTEANISSGPESNTTGITAFSMPSWQLALWATAYLALVLVAVTGNAIVIWIILA
HRRMRTVTNYFIVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVS
IYSMTAIAADRYMAIVHPFQPRLSAPSTKAVIAGIWLVALALASPQCFYSTVTMDQGATK
CVVAWPEDSGGKTLLLYHLVVIALIYFLPLAVMFVAYSVIGLTLWRRAVPGHQAHGANLR
HLQAMKKFVKTMVLVVLTFAICWLPYHLYFILGSFQEDIYCHKFIQQVYLALFWLAMSST
MYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTKEDKLELTPTTSLSTRVNRCHTKETLFMA
GDTAPSEATSGEAGRPQDGSGLWFGYGLLAPTKTHVEI
|
|
|
BDBM50081195 |
---|
n/a |
---|
Name | BDBM50081195 |
Synonyms: | CHEMBL3422010 | US10065961, Compound 1 | US10683295, Compound 1 | US10941151, Compound 1 | US9475814, 1 |
Type | Small organic molecule |
Emp. Form. | C21H19N5OS2 |
Mol. Mass. | 421.538 |
SMILES | C[C@H]1N(CCn2c1nnc2-c1csc(C)n1)C(=O)c1ccc(cc1)-c1cccs1 |r| |
Structure |
|